Key result
Severe obesity is linked to ~59% lower odds of RBC transfusions in cardiac surgery.
Why the study?
Previous studies showed conflicting data regarding the obesity paradox and the link between obesity and decreased need for RBC transfusions after cardiac surgery.
Does higher body mass index reduce 30-day mortality and red blood cell transfusions in patients undergoing open heart surgery?
Cohort (n=1,691)
No
Does higher body mass index reduce 30-day mortality and red blood cell transfusions in patients undergoing open heart surgery?
Odds Ratio: 0.41 (95% CI 0.24–0.7)
Absolute Event Rate: 29.1% vs 48.9%
p-value: p=0.001
Higher body mass index is associated with a significantly lower need for red blood cell transfusions during cardiac surgery without increasing 30-day mortality, potentially explaining the obesity paradox in this population.
Severe obesity linked to fewer transfusions without mortality difference; hypothesis-generating for obesity paradox and should not yet change practice.
OBJECTIVES: Obesity is associated with increased burden of cardiovascular risk factors, morbidity and mortality. However, several studies have counterintuitively shown better outcome after cardiac surgery in obese than in normal weight patients, a phenomenon known as obesity paradox. Furthermore, obesity has been linked with decreased need of red blood cell (RBC) transfusions. The purpose of this study was to evaluate the impact of body mass index (BMI) on 30-day mortality and RBC transfusions in patients undergoing cardiac surgery, a clinically important topic with conflicting previous data. METHODS: We retrospectively investigated 1691 patients who underwent coronary and/or valve or aortic root surgery using cardiopulmonary bypass between 2013 and 2016. The patients were categorized by BMI based on the World Health Organization classification. For analysis, logistic regression was used with adjustment for potential confounding factors. RESULTS: Of the patients, 28.7% were normal weight, 43.3% overweight, 20.5% mildly obese and 7.5% severely obese. Thirty-day mortality was 1.9% without significant differences between the BMI groups. 41.0% of patients received RBC transfusion. Overweight [odds ratio (OR) 0.75, 95% confidence interval (CI) 0.56-0.99, P = 0.045], mildly (OR 0.65, 95% CI 0.46-0.92, P = 0.016) and severely obese (OR 0.41, 95% CI 0.24-0.70, P = 0.001) patients needed less frequently RBC transfusions than patients with normal weight. CONCLUSIONS: Obesity was not associated with 30-day mortality but was associated with lower use of RBC transfusions in cardiac surgery.
No takes yet. Share an insight, caveat, or question.
Räsänen et al. (2023) conducted a cohort in Open heart surgery (n=1,691). Higher Body Mass Index (Severely Obese) vs. Normal weight (BMI 18.5-24.9) was evaluated on Need for red blood cell (RBC) transfusions (OR 0.41, 95% CI 0.24-0.70, p=0.001). Severe obesity was not associated with 30-day mortality but was associated with a significantly lower need for red blood cell transfusions (OR 0.41) compared to normal weight patients undergoing cardiac surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: